BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16985107)

  • 1. MRI of adenocarcinoma of the pancreas.
    Miller FH; Rini NJ; Keppke AL
    AJR Am J Roentgenol; 2006 Oct; 187(4):W365-74. PubMed ID: 16985107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
    Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to Progression of Pancreatic Cancer: Evaluation with Multi-Detector Computed Tomography.
    Ahn SJ; Choi SJ; Kim HS
    J Gastrointest Cancer; 2017 Jun; 48(2):164-169. PubMed ID: 27699624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.
    Kim HJ; Park MS; Lee JY; Han K; Chung YE; Choi JY; Kim MJ; Kang CM
    Cancer Res Treat; 2019 Jan; 51(1):24-33. PubMed ID: 29397657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of EUS in relation to other imaging modalities in the differential diagnosis between mass forming chronic pancreatitis, autoimmune pancreatitis and ductal pancreatic adenocarcinoma.
    Iglesias-García J; Lindkvist B; Lariño-Noia J; Domínguez-Muñoz JE
    Rev Esp Enferm Dig; 2012 Jun; 104(6):315-21. PubMed ID: 22738702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and staging of pancreatic carcinoma: MRI versus multislice-CT -- a prospective study].
    Grenacher L; Klauss M; Dukic L; Delorme S; Knaebel HP; Düx M; Kauczor HU; Büchler MW; Kauffmann GW; Richter GM
    Rofo; 2004 Nov; 176(11):1624-33. PubMed ID: 15497081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
    Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
    AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced multiphasic CT and MRI findings of adenosquamous carcinoma of the pancreas.
    Ding Y; Zhou J; Sun H; He D; Zeng M; Rao S
    Clin Imaging; 2013; 37(6):1054-60. PubMed ID: 24035524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of three-dimensional fast imaging with steady precession dynamic MR imaging in evaluating pancreatic ductal adenocarcinoma.
    Irie H; Honda H; Aibe H; Kuroiwa T; Yoshimitsu K; Shinozaki K; Yamaguchi K; Shimada M; Masuda K
    Clin Imaging; 2001; 25(1):50-6. PubMed ID: 11435041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small solid tumors (< or = 2 cm) of the pancreas: relative accuracy and differentiation of CT and MR imaging.
    Rao SX; Zeng MS; Cheng WZ; Yao XZ; Jin DY; Ji Y
    Hepatogastroenterology; 2011; 58(107-108):996-1001. PubMed ID: 21830431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of adenocarcinoma of the pancreas.
    Vachiranubhap B; Kim YH; Balci NC; Semelka RC
    Top Magn Reson Imaging; 2009 Feb; 20(1):3-9. PubMed ID: 19687720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
    Schima W; Függer R; Schober E; Oettl C; Wamser P; Grabenwöger F; Ryan JM; Novacek G
    AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T.
    Vellet AD; Romano W; Bach DB; Passi RB; Taves DH; Munk PL
    Radiology; 1992 Apr; 183(1):87-95. PubMed ID: 1312736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography.
    Raman SP; Horton KM; Fishman EK
    Cancer J; 2012; 18(6):511-22. PubMed ID: 23187837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
    Bowman AW; Bolan CW
    Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma.
    Balci NC; Semelka RC
    Eur J Radiol; 2001 May; 38(2):105-12. PubMed ID: 11335092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient arterial enhancement in a hepatic peritumoral fat-spared area.
    Unal B; Bilgili Y; Kara S; Erdal HH
    Diagn Interv Radiol; 2005 Sep; 11(3):159-62. PubMed ID: 16206058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of pancreatic ductal adenocarcinoma with spiral CT and MRI.
    Brizi MG; Natale L; Manfredi R; Barbaro B; Vecchioli A; Marano P
    Rays; 2001; 26(2):151-9. PubMed ID: 11925786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between multislice CT and MR imaging in the diagnostic evaluation of patients with pancreatic masses.
    Fusari M; Maurea S; Imbriaco M; Mollica C; Avitabile G; Soscia F; Camera L; Salvatore M
    Radiol Med; 2010 Apr; 115(3):453-66. PubMed ID: 20077047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraductal papillary mucinous tumors and mucinous cystic tumors of the pancreas: imaging.
    Choe KA
    J Hepatobiliary Pancreat Surg; 2003; 10(2):137-41. PubMed ID: 14505146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.